Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)

Clinical trial NCT05098119 · RECRUITING

Trial details

NCT number: NCT05098119
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Oral Cavity Squamous Cell Carcinoma Oral Squamous Cell Carcinoma Oropharyngeal Squamous Cell Carcinoma

Start date: 2021-09-16
Primary completion: 2024-09-16
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.